Instapaper is the simplest way to save and store articles for reading: offline, on-the-go, anytime, anywhere.

A 75-year-old man presents to your office with complaints of occasional mild hypoglycemia. His current antihyperglycemic regimen includes metformin and nateglinide. You would like to modify his treatment regimen to minimize his risk of hypoglycemia. Which one of the following 2-drug combinations would NOT be a suitable substitution? Follow the link to answer!

Diabetes educators often have mixed emotions about the use of artificially sweetened food products. On the one hand the reduction of glucose-raising sweeteners offers our patients a way to enjoy the tastes they like and still reduce calorie and carb consumption. On the flip side we often wonder if these …

Data from a longitudinal study shows that white coat hypertension and masked hypertension are both associated with increased risk of cardiovascular events.

Oftentimes patients are told, “We can give you a pill or a shot for your diabetes, and they do the same thing.” You know that they are referring to GLP-1 analogs and DPP-4 inhibitors. Since these medications have similar effects, this comparison often happens. However, this is not even close …

Younger and Older are two words that have a lot to do with the psychological effects of diabetes. We are all seeing patients being diagnosed at a Younger age, and these patients experience more problems as they become Older, due to the years of diabetes. This length of disease can …

Bernstein’s Diabetes University Videos on YouTube  Our Advisory Board member, Dr. Richard K. Bernstein, has recently created, “Dr. Bernstein’s Diabetes University,” a complete course of video classes geared towards patients, which is now available on Youtube. Dr. Bernstein’s Diabetes University Playlist includes these short videos: “Basic Science of Diabetes,” “Values …

In this week's Homerun Slides, the addition of liraglutide to insulin degludec.

Diabetes in Control publisher Steve Freed met with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. This week, Dr. Hirsch discusses the unexplainable highs, known as silent occlusions, that some patients using pumps may experience.

‘Brittle’ diabetes is a controversial and fortunately uncommon disorder, described especially in the UK and USA, usually occurring in young women, with onset at puberty, and defined as a patient whose life is ‘constantly disrupted by episodes of hypo- or hyperglycemia, whatever their cause.’